Simmons Cancer Institute is a clinical research site located in Springfield, Illinois, United States 62702.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Simmons Cancer Institute has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: AML, AML With Mutated NPM1, Hematologic Malignancy.
Sponsors: Kura Oncology, Inc., Stemline Therapeutics, Inc., Janssen Research & Development, LLC.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Simmons Cancer Institute has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Simmons Cancer Institute has 5 clinical trials on record, with 1 currently active. Their work covers AML, AML With Mutated NPM1, Hematologic Malignancy.
Yes — Simmons Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.